Related Experiment Video
Updated: Aug 11, 2025

Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
Development of a risk score for patients with ischaemic cardiomyopathy
Eduard Ródenas-Alesina1, Guillermo Romero-Farina2, Lorena Herrador1
1Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Insights
A new risk score accurately predicts major adverse cardiovascular events (MACE) in patients with ischaemic cardiomyopathy. This score uses clinical data and gated single-photon emission computed tomography (SPECT) to identify high-risk individuals needing closer monitoring.
Area of Science:
- Cardiology
- Nuclear Cardiology
- Cardiovascular Imaging
Background:
- Ischaemic cardiomyopathy is a primary cause of heart failure with significant mortality.
- Effective risk stratification is crucial for managing patients with this condition.
Purpose of the Study:
- To identify predictors of major adverse cardiovascular events (MACE) in ischaemic cardiomyopathy.
- To develop and validate a risk score for predicting MACE.
Main Methods:
- Retrospective analysis of 747 patients with ischaemic cardiomyopathy undergoing gated single-photon emission computed tomography (SPECT).
- Clinical and SPECT-derived variables were analyzed for MACE prediction using Cox regression.
- A risk score was developed and internally validated.
Main Results:
- Major adverse cardiovascular events (MACE) occurred in 41.9% of patients over a median follow-up of 4.7 years.
- Key predictors included prior heart failure, worsening symptoms, reduced kidney function, older age, diabetes, atrial fibrillation, enlarged heart chambers, and myocardial scar burden.
- The developed risk score effectively stratified patients into intermediate, high, and very high-risk categories with distinct event rates.
Conclusions:
- A straightforward risk score, utilizing readily available clinical and gated SPECT data, accurately predicts MACE risk in ischaemic cardiomyopathy.
- This tool aids in identifying patients who may benefit from intensified management strategies.
Background:
Ischaemic cardiomyopathy is a leading cause of heart failure and is associated with a poor prognosis.
Aim:
To evaluate predictors of major adverse cardiovascular events (MACE) and to develop a risk score for the disease.
Methods:
All patients with ischaemic cardiomyopathy referred to a tertiary hospital between 2010 and 2018 for stress-rest gated single-photon emission computed tomography (SPECT) were included retrospectively (n=747). Clinical and gated SPECT-derived variables were analysed as predictors of MACE, a combined endpoint of cardiovascular mortality, heart failure hospitalization or myocardial infarction during follow-up. A multivariable Cox model using backwards stepwise regression with competing risks was used to select the best parsimonious model.
Results:
After a median follow-up of 4.7 years, 313 patients had MACE (41.9%). Independent predictors of MACE were previous heart failure admission, worsening angina or dyspnoea, estimated glomerular filtration rate ≤60mL/min/1.73 m2, age>73 years, diabetes, atrial fibrillation, end-diastolic volume index>83mL/m2 and>12% of scarred myocardium. A risk score ranging from 0 to 12 classified patients as at intermediate risk (event rate of 4.0 MACE per 100 person-years), high risk (11.3 MACE per 100 person-years) or very high risk (27.8 MACE per 100 person-years). The internally validated area under the curve was 0.720 (95% confidence interval 0.660-0.740) and calibration was adequate (Hosmer-Lemeshow test P=0.28) for MACE.
Conclusions:
In patients with ischaemic cardiomyopathy, a simple risk score using dichotomic and readily available variables obtained from clinical assessment and gated SPECT accurately predicts the risk of MACE.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Cardiomyopathy I: Introduction and Classification
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

